Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy-Reference-Cited by-同舟云学术

Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy

Published:2014-06-25 Issue:8 Volume:31 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Imai Hisao,Mori Keita,Ono Akira,Akamatsu Hiroaki,Taira Tetsuhiko,Kenmotsu Hirotsugu,Naito Tateaki,Kaira Kyoichi,Murakami Haruyasu,Endo Masahiro,Nakajima Takashi,Takahashi Toshiaki

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-014-0088-3.pdf

Reference31 articles.

1. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.

2. Broglio KR, Berry DA. Detecting an overall survival benefit that is derived from progression-free survival. J Natl Cancer Inst. 2009;101:1642–9.

3. Soria JC, Massard C, Le Chevalier T. Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy? Ann Oncol. 2010;21:2324–32.

4. Reck M, von Pawel J, Zatloukal P, et al. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol. 2009;27:1227–34.

5. Saad ED, Katz A, Buyse M. Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trials. J Clin Oncol. 2010;28:1958–62.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Clinical Prediction Score for Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients;Healthcare;2023-01-18

2. Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy;Radiology and Oncology;2022-02-25

3. Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy;RADIOL ONCOL;2022

4. Post-Progression Survival Highly Influences Overall Survival in Driver Gene Mutation/Translocation Negative or Unknown Type of Non-Small Cell Lung Cancer;Oncology;2021-11-29

5. Course of postoperative relapse in non‐small cell lung cancer is strongly associated with post‐progression survival;Thoracic Cancer;2021-09-03